Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Graves Ophthalmopathy | 23 | 2024 | 133 | 11.070 |
Why?
|
Orbital Neoplasms | 21 | 2024 | 221 | 6.220 |
Why?
|
Eyelids | 21 | 2024 | 277 | 6.080 |
Why?
|
Orbit | 22 | 2024 | 446 | 4.770 |
Why?
|
Eyelid Diseases | 16 | 2024 | 157 | 4.570 |
Why?
|
Orbital Diseases | 12 | 2022 | 178 | 4.250 |
Why?
|
Eyelid Neoplasms | 9 | 2022 | 89 | 3.250 |
Why?
|
Exophthalmos | 6 | 2024 | 97 | 3.240 |
Why?
|
Ophthalmologic Surgical Procedures | 12 | 2024 | 353 | 2.850 |
Why?
|
Oculomotor Muscles | 7 | 2023 | 407 | 2.720 |
Why?
|
Dacryocystorhinostomy | 9 | 2018 | 78 | 2.550 |
Why?
|
Conjunctival Neoplasms | 7 | 2024 | 77 | 2.530 |
Why?
|
Nasolacrimal Duct | 10 | 2018 | 79 | 2.350 |
Why?
|
Lacrimal Apparatus | 8 | 2024 | 223 | 2.190 |
Why?
|
Conjunctiva | 8 | 2022 | 479 | 2.140 |
Why?
|
Blepharoplasty | 7 | 2024 | 60 | 2.030 |
Why?
|
Endoscopy | 18 | 2023 | 1834 | 1.790 |
Why?
|
Ectropion | 4 | 2020 | 27 | 1.760 |
Why?
|
Optic Nerve Diseases | 5 | 2021 | 342 | 1.750 |
Why?
|
Orbital Pseudotumor | 4 | 2016 | 42 | 1.660 |
Why?
|
Lacrimal Apparatus Diseases | 6 | 2024 | 72 | 1.620 |
Why?
|
Ophthalmology | 15 | 2024 | 549 | 1.520 |
Why?
|
Orbital Implants | 4 | 2021 | 22 | 1.510 |
Why?
|
Blepharoptosis | 7 | 2021 | 143 | 1.480 |
Why?
|
Eye Diseases | 3 | 2022 | 651 | 1.420 |
Why?
|
Eye Infections, Bacterial | 4 | 2017 | 239 | 1.380 |
Why?
|
Pemphigoid, Benign Mucous Membrane | 3 | 2023 | 115 | 1.380 |
Why?
|
Mucormycosis | 3 | 2022 | 103 | 1.360 |
Why?
|
Entropion | 3 | 2020 | 9 | 1.320 |
Why?
|
Visual Fields | 5 | 2020 | 1054 | 1.310 |
Why?
|
Orbital Fractures | 4 | 2020 | 109 | 1.270 |
Why?
|
Lacrimal Duct Obstruction | 5 | 2016 | 53 | 1.200 |
Why?
|
Intubation | 3 | 2019 | 139 | 1.140 |
Why?
|
Orbital Cellulitis | 4 | 2015 | 33 | 1.130 |
Why?
|
Dacryocystitis | 3 | 2017 | 68 | 1.050 |
Why?
|
Neurilemmoma | 3 | 2020 | 523 | 1.010 |
Why?
|
Eyebrows | 2 | 2017 | 35 | 0.990 |
Why?
|
Hemangioma, Cavernous | 4 | 2023 | 107 | 0.960 |
Why?
|
Decompression, Surgical | 6 | 2023 | 604 | 0.960 |
Why?
|
Eye Neoplasms | 3 | 2019 | 306 | 0.960 |
Why?
|
Corneal Diseases | 3 | 2019 | 536 | 0.880 |
Why?
|
Sphenoid Bone | 4 | 2021 | 177 | 0.880 |
Why?
|
Sentinel Lymph Node Biopsy | 2 | 2020 | 733 | 0.870 |
Why?
|
Nasal Cavity | 3 | 2016 | 304 | 0.870 |
Why?
|
Mucorales | 2 | 2022 | 35 | 0.850 |
Why?
|
Vision Disorders | 3 | 2019 | 1084 | 0.830 |
Why?
|
Diplopia | 6 | 2023 | 215 | 0.820 |
Why?
|
Hemochromatosis | 1 | 2024 | 174 | 0.820 |
Why?
|
Anophthalmos | 2 | 2021 | 23 | 0.790 |
Why?
|
Vascular Malformations | 2 | 2020 | 464 | 0.770 |
Why?
|
Minocycline | 1 | 2022 | 168 | 0.770 |
Why?
|
Keratoacanthoma | 1 | 2021 | 33 | 0.750 |
Why?
|
Hyperpigmentation | 1 | 2022 | 117 | 0.750 |
Why?
|
Suture Techniques | 3 | 2014 | 788 | 0.730 |
Why?
|
Frail Elderly | 2 | 2016 | 752 | 0.700 |
Why?
|
Humans | 158 | 2024 | 758381 | 0.700 |
Why?
|
Imidazoles | 2 | 2017 | 1179 | 0.690 |
Why?
|
Hydroxychloroquine | 1 | 2024 | 426 | 0.680 |
Why?
|
Tomography, X-Ray Computed | 24 | 2021 | 20500 | 0.670 |
Why?
|
Cysts | 4 | 2018 | 681 | 0.660 |
Why?
|
Ophthalmic Nerve | 1 | 2019 | 42 | 0.660 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2019 | 45 | 0.660 |
Why?
|
Biopsy | 11 | 2020 | 6768 | 0.630 |
Why?
|
Eye Injuries | 4 | 2019 | 227 | 0.630 |
Why?
|
Lymphatic Abnormalities | 1 | 2020 | 132 | 0.630 |
Why?
|
Eye Infections, Fungal | 2 | 2016 | 100 | 0.610 |
Why?
|
Technology Assessment, Biomedical | 5 | 2021 | 306 | 0.610 |
Why?
|
Factor XIIIa | 1 | 2017 | 10 | 0.610 |
Why?
|
Horner Syndrome | 1 | 2018 | 36 | 0.600 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 2 | 2018 | 178 | 0.600 |
Why?
|
Eye, Artificial | 1 | 2017 | 18 | 0.600 |
Why?
|
Retrospective Studies | 51 | 2024 | 80170 | 0.600 |
Why?
|
Academies and Institutes | 9 | 2024 | 319 | 0.600 |
Why?
|
Blepharophimosis | 1 | 2017 | 21 | 0.600 |
Why?
|
Sarcoma, Myeloid | 1 | 2018 | 51 | 0.590 |
Why?
|
Nerve Transfer | 1 | 2019 | 125 | 0.590 |
Why?
|
Nevus | 1 | 2019 | 205 | 0.580 |
Why?
|
Dermoid Cyst | 1 | 2018 | 92 | 0.580 |
Why?
|
Ectodermal Dysplasia | 1 | 2018 | 106 | 0.580 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 2017 | 64 | 0.580 |
Why?
|
Eye Hemorrhage | 1 | 2017 | 19 | 0.570 |
Why?
|
Retinal Vein Occlusion | 1 | 2018 | 149 | 0.570 |
Why?
|
Middle Aged | 68 | 2024 | 219560 | 0.570 |
Why?
|
Cranial Nerve Diseases | 1 | 2017 | 112 | 0.570 |
Why?
|
Skull Neoplasms | 1 | 2018 | 173 | 0.560 |
Why?
|
Orbit Evisceration | 1 | 2016 | 9 | 0.550 |
Why?
|
Fasciitis, Necrotizing | 1 | 2017 | 79 | 0.550 |
Why?
|
Eye Foreign Bodies | 1 | 2017 | 49 | 0.540 |
Why?
|
Port-Wine Stain | 1 | 2016 | 33 | 0.540 |
Why?
|
Cicatrix | 3 | 2019 | 781 | 0.540 |
Why?
|
Pyoderma Gangrenosum | 1 | 2017 | 84 | 0.540 |
Why?
|
Dermis | 1 | 2017 | 202 | 0.530 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2017 | 282 | 0.530 |
Why?
|
Choroid | 1 | 2018 | 350 | 0.530 |
Why?
|
Male | 82 | 2024 | 358742 | 0.530 |
Why?
|
Maxillary Sinus | 2 | 2014 | 180 | 0.530 |
Why?
|
Surgical Sponges | 1 | 2016 | 39 | 0.530 |
Why?
|
Debridement | 3 | 2017 | 492 | 0.520 |
Why?
|
Oximes | 1 | 2017 | 303 | 0.520 |
Why?
|
Sphenoid Sinus | 2 | 2018 | 99 | 0.520 |
Why?
|
Tomography, Optical Coherence | 3 | 2019 | 2880 | 0.520 |
Why?
|
Skin Neoplasms | 5 | 2024 | 5797 | 0.520 |
Why?
|
Erythema | 1 | 2017 | 262 | 0.510 |
Why?
|
Nerve Compression Syndromes | 1 | 2017 | 160 | 0.510 |
Why?
|
Mydriatics | 1 | 2015 | 67 | 0.500 |
Why?
|
Ethmoid Sinus | 1 | 2015 | 57 | 0.500 |
Why?
|
Antigens, CD34 | 1 | 2017 | 653 | 0.500 |
Why?
|
Sutures | 2 | 2014 | 293 | 0.500 |
Why?
|
Prosthesis Implantation | 3 | 2021 | 590 | 0.500 |
Why?
|
Melanoma | 4 | 2024 | 5691 | 0.500 |
Why?
|
Oculomotor Nerve | 2 | 2019 | 72 | 0.500 |
Why?
|
Paranasal Sinus Diseases | 2 | 2021 | 121 | 0.490 |
Why?
|
Glucocorticoids | 6 | 2022 | 2144 | 0.480 |
Why?
|
Phenylephrine | 1 | 2015 | 293 | 0.480 |
Why?
|
Pyrimidinones | 1 | 2017 | 383 | 0.480 |
Why?
|
Contact Lenses | 1 | 2016 | 138 | 0.480 |
Why?
|
Rhabdomyosarcoma | 1 | 2017 | 358 | 0.480 |
Why?
|
Hernia | 1 | 2014 | 68 | 0.470 |
Why?
|
Aged, 80 and over | 25 | 2024 | 58681 | 0.470 |
Why?
|
Skin Transplantation | 2 | 2019 | 1083 | 0.470 |
Why?
|
Female | 80 | 2024 | 390316 | 0.460 |
Why?
|
Skin Aging | 1 | 2015 | 141 | 0.460 |
Why?
|
Myxoma | 1 | 2014 | 114 | 0.460 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2018 | 586 | 0.460 |
Why?
|
Eyelashes | 1 | 2014 | 19 | 0.460 |
Why?
|
Fluorescein Angiography | 2 | 2018 | 1044 | 0.450 |
Why?
|
Ophthalmic Artery | 1 | 2014 | 58 | 0.450 |
Why?
|
Alopecia | 1 | 2018 | 414 | 0.450 |
Why?
|
Eye Infections, Viral | 1 | 2014 | 60 | 0.450 |
Why?
|
Hyperglycemia | 1 | 2022 | 1368 | 0.440 |
Why?
|
Panophthalmitis | 1 | 2013 | 6 | 0.440 |
Why?
|
Edema | 2 | 2017 | 768 | 0.440 |
Why?
|
Nerve Regeneration | 1 | 2019 | 791 | 0.440 |
Why?
|
Facial Paralysis | 1 | 2017 | 345 | 0.440 |
Why?
|
Chalazion | 1 | 2013 | 10 | 0.440 |
Why?
|
Aged | 48 | 2024 | 168217 | 0.440 |
Why?
|
Alendronate | 1 | 2014 | 172 | 0.430 |
Why?
|
Keratins | 2 | 2016 | 497 | 0.420 |
Why?
|
Streptococcal Infections | 1 | 2017 | 617 | 0.410 |
Why?
|
Rhabdoid Tumor | 1 | 2014 | 210 | 0.410 |
Why?
|
Carcinoma | 2 | 2015 | 2330 | 0.410 |
Why?
|
Terminology as Topic | 1 | 2019 | 1533 | 0.410 |
Why?
|
Lymphatic Metastasis | 1 | 2020 | 2943 | 0.410 |
Why?
|
Cornea | 2 | 2019 | 1326 | 0.400 |
Why?
|
Emphysema | 1 | 2015 | 240 | 0.400 |
Why?
|
Pyridones | 1 | 2017 | 785 | 0.400 |
Why?
|
Muscle Weakness | 1 | 2015 | 413 | 0.400 |
Why?
|
Fever | 3 | 2021 | 1617 | 0.400 |
Why?
|
Surgical Flaps | 6 | 2022 | 1669 | 0.380 |
Why?
|
Keratosis, Actinic | 1 | 2012 | 72 | 0.380 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 694 | 0.370 |
Why?
|
Adipose Tissue | 3 | 2021 | 3299 | 0.350 |
Why?
|
Nose | 3 | 2023 | 519 | 0.350 |
Why?
|
Foreign Bodies | 1 | 2014 | 397 | 0.350 |
Why?
|
Cocaine-Related Disorders | 1 | 2013 | 461 | 0.340 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2015 | 574 | 0.340 |
Why?
|
Neuroblastoma | 1 | 2018 | 1251 | 0.340 |
Why?
|
Immunohistochemistry | 6 | 2019 | 11070 | 0.330 |
Why?
|
Diphosphonates | 1 | 2014 | 636 | 0.330 |
Why?
|
Blindness | 1 | 2013 | 582 | 0.330 |
Why?
|
Escherichia coli Infections | 1 | 2013 | 523 | 0.320 |
Why?
|
Strabismus | 2 | 2024 | 317 | 0.320 |
Why?
|
Lymph Nodes | 1 | 2020 | 3485 | 0.320 |
Why?
|
Football | 1 | 2014 | 502 | 0.320 |
Why?
|
Herpesvirus 4, Human | 1 | 2014 | 1075 | 0.310 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2021 | 4023 | 0.310 |
Why?
|
Staphylococcal Infections | 1 | 2017 | 1406 | 0.310 |
Why?
|
Adult | 42 | 2024 | 219916 | 0.310 |
Why?
|
Craniopharyngioma | 2 | 2001 | 277 | 0.300 |
Why?
|
Receptors, Cell Surface | 1 | 2017 | 2825 | 0.300 |
Why?
|
Cocaine | 1 | 2013 | 958 | 0.300 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2019 | 1627 | 0.300 |
Why?
|
Visual Field Tests | 3 | 2019 | 411 | 0.300 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2014 | 608 | 0.300 |
Why?
|
B-Lymphocytes | 3 | 2018 | 4738 | 0.290 |
Why?
|
Retina | 1 | 2018 | 2637 | 0.290 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2017 | 2053 | 0.290 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2012 | 1066 | 0.290 |
Why?
|
Geriatric Assessment | 1 | 2015 | 1404 | 0.290 |
Why?
|
Eye Enucleation | 4 | 2021 | 128 | 0.280 |
Why?
|
Dry Eye Syndromes | 2 | 2023 | 385 | 0.280 |
Why?
|
Antigens, CD | 1 | 2017 | 3997 | 0.280 |
Why?
|
Stents | 2 | 2019 | 3162 | 0.280 |
Why?
|
Bone Density Conservation Agents | 1 | 2014 | 794 | 0.280 |
Why?
|
Self Report | 2 | 2016 | 3712 | 0.280 |
Why?
|
Hypesthesia | 2 | 2019 | 107 | 0.270 |
Why?
|
Anesthetics, Local | 1 | 2013 | 1000 | 0.270 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2014 | 2825 | 0.270 |
Why?
|
Magnetic Resonance Imaging | 19 | 2019 | 36285 | 0.260 |
Why?
|
Treatment Outcome | 19 | 2023 | 64379 | 0.260 |
Why?
|
Germany | 3 | 2016 | 868 | 0.260 |
Why?
|
Molecular Targeted Therapy | 2 | 2016 | 2796 | 0.250 |
Why?
|
Bone Neoplasms | 1 | 2018 | 2531 | 0.250 |
Why?
|
Ultrasonography | 1 | 2019 | 5952 | 0.250 |
Why?
|
Diagnosis, Differential | 9 | 2021 | 12951 | 0.250 |
Why?
|
Surgery, Plastic | 1 | 2012 | 643 | 0.250 |
Why?
|
Psychometrics | 1 | 2015 | 3050 | 0.250 |
Why?
|
Conjunctival Diseases | 2 | 2016 | 110 | 0.250 |
Why?
|
Skin Abnormalities | 2 | 2017 | 59 | 0.250 |
Why?
|
Disease Management | 1 | 2016 | 2500 | 0.250 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1402 | 0.250 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 1547 | 0.250 |
Why?
|
Nasal Mucosa | 2 | 2018 | 412 | 0.240 |
Why?
|
Paranasal Sinuses | 2 | 2017 | 265 | 0.230 |
Why?
|
Antineoplastic Agents | 5 | 2024 | 13591 | 0.230 |
Why?
|
Quality of Life | 5 | 2022 | 13286 | 0.220 |
Why?
|
Quality Improvement | 1 | 2019 | 3806 | 0.220 |
Why?
|
Conjunctivitis | 1 | 2024 | 155 | 0.220 |
Why?
|
Pigmentation Disorders | 1 | 2024 | 105 | 0.220 |
Why?
|
Follow-Up Studies | 12 | 2019 | 39060 | 0.220 |
Why?
|
Epidermal Cyst | 2 | 2016 | 64 | 0.210 |
Why?
|
Receptors, Thyrotropin | 1 | 2022 | 45 | 0.210 |
Why?
|
Postoperative Complications | 6 | 2024 | 15638 | 0.200 |
Why?
|
Pituitary Neoplasms | 2 | 2001 | 1313 | 0.200 |
Why?
|
Materia Medica | 1 | 2021 | 14 | 0.200 |
Why?
|
Dioxygenases | 1 | 2024 | 332 | 0.190 |
Why?
|
Ecchymosis | 1 | 2021 | 32 | 0.190 |
Why?
|
Anilides | 1 | 2024 | 409 | 0.190 |
Why?
|
Face | 3 | 2023 | 1017 | 0.190 |
Why?
|
Otolaryngology | 2 | 2020 | 685 | 0.190 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5629 | 0.190 |
Why?
|
Salmonella enteritidis | 1 | 2000 | 16 | 0.180 |
Why?
|
Oxazolone | 1 | 2020 | 61 | 0.180 |
Why?
|
Systemic Vasculitis | 1 | 2020 | 36 | 0.180 |
Why?
|
Polyhydroxyethyl Methacrylate | 1 | 2019 | 30 | 0.170 |
Why?
|
Giant Cell Arteritis | 1 | 2024 | 297 | 0.170 |
Why?
|
Hedgehog Proteins | 1 | 2024 | 769 | 0.170 |
Why?
|
Streptavidin | 1 | 1999 | 82 | 0.170 |
Why?
|
Optic Nerve Injuries | 1 | 2020 | 147 | 0.170 |
Why?
|
Maxillary Fractures | 1 | 2019 | 21 | 0.160 |
Why?
|
Scleral Buckling | 1 | 2019 | 95 | 0.160 |
Why?
|
Zygomatic Fractures | 1 | 2019 | 35 | 0.160 |
Why?
|
Prevalence | 1 | 2016 | 15646 | 0.160 |
Why?
|
Tears | 2 | 2020 | 251 | 0.160 |
Why?
|
Sclerotherapy | 1 | 2020 | 180 | 0.160 |
Why?
|
Food Contamination | 1 | 2000 | 192 | 0.160 |
Why?
|
Salmonella Infections | 1 | 2000 | 171 | 0.160 |
Why?
|
Carcinoma, Basal Cell | 1 | 2024 | 559 | 0.160 |
Why?
|
Rupture | 4 | 2014 | 443 | 0.160 |
Why?
|
Vitamin K | 1 | 2021 | 318 | 0.160 |
Why?
|
Alphapapillomavirus | 1 | 2021 | 219 | 0.160 |
Why?
|
Hemianopsia | 1 | 2000 | 121 | 0.160 |
Why?
|
Biotin | 1 | 1999 | 253 | 0.150 |
Why?
|
Facial Neoplasms | 1 | 2019 | 125 | 0.150 |
Why?
|
Palate, Hard | 1 | 2018 | 58 | 0.150 |
Why?
|
Drug Therapy, Combination | 3 | 2017 | 6293 | 0.150 |
Why?
|
Adolescent | 14 | 2023 | 87888 | 0.150 |
Why?
|
Preoperative Period | 2 | 2017 | 553 | 0.150 |
Why?
|
Plant Extracts | 1 | 2021 | 489 | 0.150 |
Why?
|
Penicillin G | 1 | 2017 | 41 | 0.150 |
Why?
|
Blinking | 2 | 2017 | 133 | 0.150 |
Why?
|
Corneal Ulcer | 2 | 2017 | 128 | 0.150 |
Why?
|
Combined Modality Therapy | 3 | 2017 | 8530 | 0.140 |
Why?
|
Sampling Studies | 1 | 2019 | 614 | 0.140 |
Why?
|
Lacerations | 1 | 2019 | 148 | 0.140 |
Why?
|
Nuclear Medicine | 1 | 2020 | 236 | 0.140 |
Why?
|
Cadaver | 3 | 2019 | 1345 | 0.140 |
Why?
|
Fundus Oculi | 1 | 2018 | 541 | 0.140 |
Why?
|
Submandibular Gland | 1 | 2017 | 87 | 0.140 |
Why?
|
Streptococcus | 1 | 2017 | 198 | 0.140 |
Why?
|
Cautery | 1 | 2017 | 71 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2020 | 9273 | 0.130 |
Why?
|
Visual Acuity | 6 | 2016 | 2642 | 0.130 |
Why?
|
Surgery, Computer-Assisted | 1 | 2024 | 1008 | 0.130 |
Why?
|
Optic Disk | 1 | 2020 | 421 | 0.130 |
Why?
|
Exanthema | 1 | 2021 | 504 | 0.130 |
Why?
|
Silicone Elastomers | 1 | 2016 | 78 | 0.130 |
Why?
|
Anti-Bacterial Agents | 4 | 2022 | 7403 | 0.130 |
Why?
|
Pigmentation | 1 | 2016 | 144 | 0.130 |
Why?
|
Carotid-Cavernous Sinus Fistula | 1 | 2016 | 37 | 0.130 |
Why?
|
Panuveitis | 1 | 2016 | 33 | 0.130 |
Why?
|
Hospitals, Special | 1 | 2016 | 91 | 0.130 |
Why?
|
Eye Pain | 2 | 2013 | 46 | 0.130 |
Why?
|
Infant | 7 | 2023 | 36054 | 0.130 |
Why?
|
Models, Anatomic | 1 | 2019 | 681 | 0.130 |
Why?
|
Gels | 1 | 2017 | 419 | 0.130 |
Why?
|
Immunoglobulin G | 3 | 2023 | 4540 | 0.130 |
Why?
|
Hair Diseases | 1 | 2016 | 72 | 0.130 |
Why?
|
Melanosis | 1 | 2016 | 93 | 0.130 |
Why?
|
Histiocytes | 1 | 2015 | 98 | 0.130 |
Why?
|
Antibodies, Blocking | 1 | 2016 | 242 | 0.120 |
Why?
|
United States | 12 | 2024 | 72140 | 0.120 |
Why?
|
Frontal Lobe | 1 | 2001 | 1419 | 0.120 |
Why?
|
Silicones | 1 | 2016 | 227 | 0.120 |
Why?
|
Fusobacterium necrophorum | 1 | 2014 | 14 | 0.120 |
Why?
|
Cavernous Sinus Thrombosis | 1 | 2014 | 14 | 0.120 |
Why?
|
Lymphangiogenesis | 1 | 2016 | 172 | 0.120 |
Why?
|
Neovascularization, Pathologic | 2 | 2016 | 2638 | 0.120 |
Why?
|
Lemierre Syndrome | 1 | 2014 | 14 | 0.120 |
Why?
|
Eye Injuries, Penetrating | 3 | 1994 | 121 | 0.120 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2018 | 546 | 0.120 |
Why?
|
Societies, Medical | 2 | 2019 | 3891 | 0.120 |
Why?
|
Retinal Cone Photoreceptor Cells | 1 | 2015 | 180 | 0.120 |
Why?
|
Glass | 1 | 2014 | 115 | 0.120 |
Why?
|
Antifungal Agents | 2 | 2016 | 749 | 0.120 |
Why?
|
Bioartificial Organs | 1 | 2014 | 47 | 0.110 |
Why?
|
Antirheumatic Agents | 1 | 2024 | 1368 | 0.110 |
Why?
|
Consensus | 2 | 2020 | 3099 | 0.110 |
Why?
|
Vancomycin | 1 | 2017 | 503 | 0.110 |
Why?
|
Hair Follicle | 1 | 2016 | 210 | 0.110 |
Why?
|
Translating | 1 | 2015 | 143 | 0.110 |
Why?
|
Lymph Node Excision | 1 | 2020 | 1303 | 0.110 |
Why?
|
Young Adult | 7 | 2018 | 58808 | 0.110 |
Why?
|
Remission, Spontaneous | 1 | 2014 | 384 | 0.110 |
Why?
|
Massachusetts | 2 | 2017 | 8823 | 0.110 |
Why?
|
Eye Burns | 1 | 2014 | 65 | 0.110 |
Why?
|
Parotid Gland | 1 | 2014 | 175 | 0.110 |
Why?
|
False Negative Reactions | 1 | 2015 | 573 | 0.110 |
Why?
|
Leiomyosarcoma | 1 | 2017 | 424 | 0.110 |
Why?
|
Prostaglandins, Synthetic | 1 | 2013 | 24 | 0.110 |
Why?
|
Documentation | 1 | 2020 | 892 | 0.110 |
Why?
|
Communicable Diseases | 1 | 2022 | 877 | 0.110 |
Why?
|
Aspergillosis | 1 | 2015 | 243 | 0.110 |
Why?
|
Microscopy, Confocal | 1 | 2019 | 1969 | 0.110 |
Why?
|
Burns, Chemical | 1 | 2014 | 122 | 0.110 |
Why?
|
Viscosupplements | 1 | 2013 | 21 | 0.110 |
Why?
|
Granuloma, Foreign-Body | 1 | 2013 | 42 | 0.110 |
Why?
|
Sirolimus | 1 | 2020 | 1533 | 0.110 |
Why?
|
Endoscopes | 1 | 2013 | 168 | 0.100 |
Why?
|
Carcinoma, Lobular | 1 | 2017 | 489 | 0.100 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1705 | 0.100 |
Why?
|
Rupture, Spontaneous | 1 | 2013 | 353 | 0.100 |
Why?
|
Pyridines | 1 | 2024 | 2860 | 0.100 |
Why?
|
Antibodies, Monoclonal | 2 | 2022 | 9160 | 0.100 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2019 | 1214 | 0.100 |
Why?
|
Azithromycin | 1 | 2013 | 200 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 2 | 2021 | 1870 | 0.100 |
Why?
|
Ophthalmoplegia | 1 | 2013 | 168 | 0.100 |
Why?
|
Imaging, Three-Dimensional | 3 | 2017 | 4048 | 0.100 |
Why?
|
Administration, Intranasal | 1 | 2013 | 471 | 0.100 |
Why?
|
Meningeal Neoplasms | 1 | 2020 | 1247 | 0.100 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2014 | 649 | 0.100 |
Why?
|
Nasopharyngeal Diseases | 1 | 2011 | 26 | 0.100 |
Why?
|
Child | 8 | 2020 | 79813 | 0.100 |
Why?
|
Reproducibility of Results | 3 | 2023 | 20052 | 0.090 |
Why?
|
Fluoroquinolones | 1 | 2013 | 308 | 0.090 |
Why?
|
Uveitis | 1 | 2015 | 393 | 0.090 |
Why?
|
Botulinum Toxins | 1 | 2013 | 187 | 0.090 |
Why?
|
Graft vs Host Disease | 1 | 2023 | 3024 | 0.090 |
Why?
|
Hemangioma | 1 | 2016 | 727 | 0.090 |
Why?
|
Abscess | 2 | 2014 | 605 | 0.090 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 5246 | 0.090 |
Why?
|
Mycoses | 1 | 2014 | 386 | 0.090 |
Why?
|
Paraproteinemias | 1 | 2013 | 246 | 0.090 |
Why?
|
Ultraviolet Rays | 1 | 2015 | 1076 | 0.090 |
Why?
|
Muscle Contraction | 1 | 2015 | 1196 | 0.090 |
Why?
|
Inflammation | 4 | 2022 | 10719 | 0.090 |
Why?
|
In Situ Hybridization | 1 | 2014 | 1900 | 0.090 |
Why?
|
Lymphocytes | 1 | 2018 | 2610 | 0.090 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11152 | 0.090 |
Why?
|
Breast Neoplasms | 3 | 2017 | 21017 | 0.090 |
Why?
|
Radiography | 3 | 2015 | 6955 | 0.080 |
Why?
|
Molecular Biology | 1 | 2013 | 580 | 0.080 |
Why?
|
Mohs Surgery | 1 | 2012 | 221 | 0.080 |
Why?
|
Infarction | 1 | 2011 | 247 | 0.080 |
Why?
|
Papillomavirus Infections | 1 | 2021 | 1612 | 0.080 |
Why?
|
Gene Rearrangement | 1 | 2014 | 1122 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2020 | 3480 | 0.080 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2016 | 1651 | 0.080 |
Why?
|
Postoperative Care | 1 | 2015 | 1471 | 0.080 |
Why?
|
Uterine Neoplasms | 1 | 2017 | 1439 | 0.080 |
Why?
|
Lung Neoplasms | 3 | 2009 | 13245 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2017 | 1793 | 0.070 |
Why?
|
Thyroid Neoplasms | 1 | 2020 | 2332 | 0.070 |
Why?
|
Sinusitis | 1 | 2015 | 990 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3609 | 0.060 |
Why?
|
Viral Load | 1 | 2014 | 3321 | 0.060 |
Why?
|
Graft Survival | 1 | 2015 | 3794 | 0.060 |
Why?
|
Polymerase Chain Reaction | 1 | 2014 | 6068 | 0.060 |
Why?
|
Meige Syndrome | 1 | 2004 | 12 | 0.060 |
Why?
|
Fatal Outcome | 1 | 2009 | 1829 | 0.060 |
Why?
|
Radiodermatitis | 1 | 2024 | 58 | 0.060 |
Why?
|
Wound Healing | 1 | 2015 | 2783 | 0.060 |
Why?
|
Blepharospasm | 1 | 2004 | 29 | 0.060 |
Why?
|
Cyanobacteria | 1 | 2004 | 50 | 0.060 |
Why?
|
Amyloidosis | 1 | 2011 | 817 | 0.060 |
Why?
|
Immunotherapy | 1 | 2019 | 4641 | 0.050 |
Why?
|
Infant, Newborn | 3 | 2018 | 26182 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 2244 | 0.050 |
Why?
|
Glaucoma | 1 | 2013 | 1182 | 0.050 |
Why?
|
Recurrence | 1 | 2015 | 8426 | 0.050 |
Why?
|
Health Status | 1 | 2016 | 4069 | 0.050 |
Why?
|
Antibodies, Viral | 1 | 2014 | 3142 | 0.050 |
Why?
|
Disease Progression | 1 | 2019 | 13468 | 0.050 |
Why?
|
Neuromuscular Agents | 1 | 2004 | 148 | 0.050 |
Why?
|
Radiotherapy | 1 | 2009 | 1504 | 0.050 |
Why?
|
Anemia, Sickle Cell | 1 | 2011 | 1054 | 0.050 |
Why?
|
Meibomian Glands | 1 | 2022 | 73 | 0.050 |
Why?
|
Health Surveys | 1 | 2012 | 4060 | 0.050 |
Why?
|
Dermatology | 1 | 2012 | 914 | 0.050 |
Why?
|
Survival Rate | 1 | 2016 | 12721 | 0.050 |
Why?
|
Philadelphia | 2 | 1992 | 265 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18357 | 0.050 |
Why?
|
Eye Evisceration | 1 | 2021 | 22 | 0.050 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2015 | 1852 | 0.050 |
Why?
|
Neoplasm Seeding | 1 | 2001 | 84 | 0.050 |
Why?
|
Cyclin A | 1 | 2001 | 60 | 0.050 |
Why?
|
Iopamidol | 1 | 2002 | 186 | 0.050 |
Why?
|
Uveal Neoplasms | 1 | 2024 | 341 | 0.050 |
Why?
|
Botulinum Toxins, Type A | 1 | 2004 | 229 | 0.050 |
Why?
|
Prognosis | 2 | 2020 | 29558 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2001 | 8981 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2023 | 979 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14641 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2002 | 651 | 0.040 |
Why?
|
Prospective Studies | 3 | 2020 | 54136 | 0.040 |
Why?
|
Referral and Consultation | 1 | 2012 | 3586 | 0.040 |
Why?
|
Time Factors | 3 | 2016 | 39873 | 0.040 |
Why?
|
Salivary Glands | 1 | 2020 | 229 | 0.040 |
Why?
|
Eggs | 1 | 2000 | 183 | 0.040 |
Why?
|
Bioengineering | 1 | 2019 | 96 | 0.040 |
Why?
|
Hydrolysis | 1 | 2019 | 664 | 0.040 |
Why?
|
Scalp | 1 | 2021 | 389 | 0.040 |
Why?
|
Echo-Planar Imaging | 1 | 2002 | 657 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10171 | 0.040 |
Why?
|
S100 Proteins | 1 | 2018 | 218 | 0.040 |
Why?
|
Vimentin | 1 | 2018 | 255 | 0.040 |
Why?
|
Thermodynamics | 1 | 1999 | 595 | 0.040 |
Why?
|
Fluoroscopy | 1 | 2002 | 944 | 0.040 |
Why?
|
Aneuploidy | 1 | 2001 | 551 | 0.040 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2019 | 119 | 0.040 |
Why?
|
Risk Assessment | 1 | 2019 | 23883 | 0.040 |
Why?
|
Radiation Injuries | 1 | 2024 | 1182 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11709 | 0.040 |
Why?
|
Benchmarking | 1 | 2023 | 1042 | 0.030 |
Why?
|
Iodine Radioisotopes | 1 | 2020 | 1032 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2017 | 4901 | 0.030 |
Why?
|
Drainage | 2 | 2014 | 1161 | 0.030 |
Why?
|
Scleritis | 1 | 2017 | 96 | 0.030 |
Why?
|
Administration, Oral | 1 | 2024 | 3993 | 0.030 |
Why?
|
Aging | 1 | 2015 | 8651 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1999 | 1693 | 0.030 |
Why?
|
Craniotomy | 1 | 2000 | 741 | 0.030 |
Why?
|
Delphi Technique | 1 | 2019 | 829 | 0.030 |
Why?
|
Lymphoma | 1 | 2024 | 1896 | 0.030 |
Why?
|
Retinal Detachment | 1 | 2019 | 428 | 0.030 |
Why?
|
Papillomaviridae | 1 | 2021 | 1121 | 0.030 |
Why?
|
Nasal Septum | 1 | 2016 | 130 | 0.030 |
Why?
|
Aspergillus | 1 | 2015 | 92 | 0.030 |
Why?
|
Head | 1 | 2021 | 921 | 0.030 |
Why?
|
Parotitis | 1 | 2014 | 28 | 0.030 |
Why?
|
Cell Adhesion Molecules | 1 | 2001 | 1600 | 0.030 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2016 | 747 | 0.030 |
Why?
|
Crystallography, X-Ray | 1 | 1999 | 1974 | 0.030 |
Why?
|
Hyperbaric Oxygenation | 1 | 2015 | 165 | 0.030 |
Why?
|
Travel | 1 | 2000 | 785 | 0.030 |
Why?
|
Optic Nerve | 1 | 2017 | 567 | 0.030 |
Why?
|
Fibroblasts | 1 | 2024 | 4087 | 0.030 |
Why?
|
Cloprostenol | 1 | 2013 | 21 | 0.030 |
Why?
|
Prostaglandins F, Synthetic | 1 | 2013 | 32 | 0.030 |
Why?
|
Child, Preschool | 5 | 2016 | 42058 | 0.030 |
Why?
|
Melanocytes | 1 | 2016 | 509 | 0.030 |
Why?
|
Meningitis | 1 | 2014 | 218 | 0.030 |
Why?
|
Pharyngitis | 1 | 2014 | 219 | 0.030 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2016 | 666 | 0.030 |
Why?
|
Cohort Studies | 1 | 2015 | 41252 | 0.030 |
Why?
|
Postoperative Period | 1 | 2017 | 1812 | 0.030 |
Why?
|
Polymers | 1 | 2019 | 1615 | 0.030 |
Why?
|
Lymphatic Vessels | 1 | 2016 | 358 | 0.020 |
Why?
|
Tumor Burden | 1 | 2017 | 1893 | 0.020 |
Why?
|
Ketone Bodies | 1 | 1991 | 76 | 0.020 |
Why?
|
Prednisone | 1 | 2016 | 1565 | 0.020 |
Why?
|
Clavulanic Acid | 1 | 2010 | 19 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2004 | 3824 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2000 | 1755 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2014 | 1593 | 0.020 |
Why?
|
Cerebral Angiography | 1 | 2016 | 1275 | 0.020 |
Why?
|
Pneumonia | 1 | 2002 | 2129 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2016 | 22031 | 0.020 |
Why?
|
Amides | 1 | 2013 | 447 | 0.020 |
Why?
|
Carotid Arteries | 1 | 2014 | 939 | 0.020 |
Why?
|
Prednisolone | 1 | 2011 | 326 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 1991 | 392 | 0.020 |
Why?
|
Subcutaneous Fat | 1 | 2013 | 393 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3356 | 0.020 |
Why?
|
Chronic Disease | 1 | 2024 | 9266 | 0.020 |
Why?
|
Ocular Motility Disorders | 1 | 2011 | 144 | 0.020 |
Why?
|
Growth Hormone | 1 | 1991 | 568 | 0.020 |
Why?
|
Registries | 2 | 2024 | 8176 | 0.020 |
Why?
|
Positron-Emission Tomography | 2 | 2017 | 6457 | 0.020 |
Why?
|
Amoxicillin | 1 | 2010 | 180 | 0.020 |
Why?
|
Brachytherapy | 1 | 2017 | 1236 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 2001 | 1919 | 0.020 |
Why?
|
Contrast Media | 1 | 2002 | 5298 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2002 | 8946 | 0.020 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2010 | 343 | 0.020 |
Why?
|
Reoperation | 1 | 2018 | 4282 | 0.020 |
Why?
|
DNA | 1 | 2001 | 7199 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 25953 | 0.020 |
Why?
|
Demography | 1 | 1992 | 1651 | 0.020 |
Why?
|
Mutation | 2 | 2024 | 29915 | 0.020 |
Why?
|
Incidence | 2 | 2024 | 21273 | 0.020 |
Why?
|
Protein Binding | 1 | 1999 | 9312 | 0.020 |
Why?
|
Proteomics | 1 | 2020 | 3816 | 0.020 |
Why?
|
Embolization, Therapeutic | 1 | 2016 | 1407 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2024 | 9575 | 0.020 |
Why?
|
Hypothalamus | 1 | 1991 | 998 | 0.020 |
Why?
|
Seasons | 1 | 1992 | 1519 | 0.020 |
Why?
|
Wounds, Nonpenetrating | 1 | 1992 | 793 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2011 | 2210 | 0.020 |
Why?
|
Risk Factors | 6 | 2015 | 73806 | 0.020 |
Why?
|
Smoking | 1 | 2023 | 9042 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8554 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2001 | 8506 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15785 | 0.010 |
Why?
|
Pain | 1 | 2019 | 5065 | 0.010 |
Why?
|
Muscle Relaxation | 1 | 2004 | 138 | 0.010 |
Why?
|
Functional Laterality | 1 | 2011 | 2252 | 0.010 |
Why?
|
Software | 1 | 2017 | 4416 | 0.010 |
Why?
|
Diet | 1 | 2000 | 8003 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2001 | 6852 | 0.010 |
Why?
|
DNA Fingerprinting | 1 | 2001 | 111 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2016 | 12760 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18125 | 0.010 |
Why?
|
Glucose | 1 | 1991 | 4336 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12096 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 2004 | 2048 | 0.010 |
Why?
|
Phantoms, Imaging | 1 | 2002 | 2509 | 0.010 |
Why?
|
Northwest Territories | 1 | 1993 | 1 | 0.010 |
Why?
|
Animals | 3 | 2020 | 167777 | 0.010 |
Why?
|
Mice | 1 | 2020 | 81107 | 0.010 |
Why?
|
Swine | 1 | 2002 | 5892 | 0.010 |
Why?
|
Nicotinic Acids | 1 | 1991 | 31 | 0.010 |
Why?
|
Image Enhancement | 1 | 2002 | 2880 | 0.010 |
Why?
|
Injections, Intraventricular | 1 | 1991 | 225 | 0.010 |
Why?
|
Oleic Acids | 1 | 1991 | 74 | 0.010 |
Why?
|
Hydroxybutyrates | 1 | 1991 | 79 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2004 | 12262 | 0.010 |
Why?
|
Indians, North American | 1 | 1993 | 350 | 0.010 |
Why?
|
Macaca mulatta | 1 | 1991 | 2316 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 2001 | 15225 | 0.000 |
Why?
|
Rectal Neoplasms | 1 | 1993 | 1152 | 0.000 |
Why?
|
Neoplasms | 1 | 1993 | 22030 | 0.000 |
Why?
|
Hydrocortisone | 1 | 1991 | 1802 | 0.000 |
Why?
|
Colonic Neoplasms | 1 | 1993 | 2523 | 0.000 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1993 | 2016 | 0.000 |
Why?
|
Insulin | 1 | 1991 | 6578 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 1993 | 11336 | 0.000 |
Why?
|